A reproducible strategy for analysis of minimal residual disease measured by Standardized multiparametric flow cytometry in b acute lymphoblastic leukemia

Cytometry B Clin Cytom. 2019 Jan;96(1):12-15. doi: 10.1002/cyto.b.21720. Epub 2018 Oct 24.

Authors

Hector Sarmiento Palao¹, Fabián Tarín¹, Fernanda Martirena², Eva Barragán³, Esperanza Such³, Amparo Sempere³, Maria Tasso⁴, Pablo Manresa¹, Francisco López¹

Affiliations

¹ Department of Hematology, Hospital General Universitari d'Alacant.
² Department of Hematology, Hospital General de Elda.
³ Department of Hematology, Hospital Universitario La Fe de Valencia.
⁴ Department of Pediatrics, Hospital General Universitari d'Alacant.

PMID: 30353651
DOI: 10.1002/cyto.b.21720

No abstract available

Publication types

Letter
Comment

MeSH terms

B-Lymphocytes
Burkitt Lymphoma*
Flow Cytometry
Humans
Neoplasm, Residual
Precursor Cell Lymphoblastic Leukemia-Lymphoma*